
At Richmond Pharmacology, patient safety is at the heart of every clinical trial. Our dedicated Pharmacovigilance (PV) team ensures that all safety data are captured, assessed and reported in compliance with global regulatory standards.
Pharmacovigilance is the science of monitoring and preventing adverse effects. It safeguards trial participants, ensures regulators and sponsors can act on emerging data, and underpins confidence in new medicines.
Recording and evaluation of all adverse events, including those unrelated to the trial
Rigorous review of serious adverse events by our safety team and Principal Investigators
Tailored processes depending on the complexity of the trial, always aligned with regulatory requirements
Ethical governance in line with international safety frameworks
Close collaboration with investigators, doctors and sponsors to ensure patient protection
Our PV processes have been developed to the highest standards, ensuring no important safety event is missed.
Every adverse event is recorded, reviewed and reported.
Tailored processes designed to match each trial’s complexity, ensuring all safety data are captured, assessed, and reported in alignment with regulatory requirements.
Recording and evaluation of all adverse events, including those unrelated to the trial, to ensure no important safety event is missed.
Rigorous review of serious adverse events by our safety team and Principal Investigators, with prompt reporting to sponsors, regulators, and ethics committees.
Proactive monitoring to identify emerging safety signals early, enabling timely escalation and action in line with international safety frameworks.
Close collaboration between investigators, doctors, and sponsors ensures ethical governance and participant protection throughout every stage of the study.
Continuous pharmacovigilance training maintains compliance and awareness across all teams, supporting consistent adherence to global standards.
Our Pharmacovigilance systems operate in full compliance with ICH Guidelines, CIOMS VI Working Group recommendations, and The Medicines for Human Use (Clinical Trials) Regulations.
These frameworks ensure that every aspect of our safety monitoring meets the highest global regulatory standards.

Our Pharmacovigilance team includes experienced Drug Safety Monitors, safety physicians and clinical staff. Working together with Doctors, they bring expertise in early-phase research and ensure the highest standards of participant safety and regulatory compliance.